Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar-Apr;69(2):211-223.
doi: 10.1016/j.survophthal.2023.11.002. Epub 2023 Nov 8.

In praise of povidone-iodine application in ophthalmology

Affiliations
Review

In praise of povidone-iodine application in ophthalmology

Mohammad Soleimani et al. Surv Ophthalmol. 2024 Mar-Apr.

Abstract

Polyvinyl pyrrolidone or povidone-iodine (PVP-I) is a water-soluble complex formed by the combination of iodine and a water-soluble polymer, polyvinyl pyrrolidone. This complex exerts bactericidal, fungicidal, and virucidal action by gradually releasing free iodine at the site of application to react with pathogens. In ophthalmology, PVP-I is used as a disinfectant and antiseptic agent for preoperative preparation of the skin and mucous membranes and for treating contaminated wounds. PVP-I has been shown to reduce effectively the risk of endophthalmitis in various ocular procedures, including cataract surgery and intravitreal injections; however, it has also been used in the treatment of conjunctivitis, keratitis, and endophthalmitis, with promising results especially in low-resource situations. PVP-I has been associated with complications such as postoperative eye pain, persistent corneal epithelial defects, ocular inflammation, and an attendant risk of keratitis. In cases of poor PVP-I tolerance, applying PVP-I at lower concentrations or using alternative antiseptics such as chlorhexidine should be considered. We provide an update on the efficacy of PVP-I in the prophylaxis and treatment of conjunctivitis, keratitis, and endophthalmitis and a comprehensive analysis of the current literature regarding the use of PVP-I in the management of these ocular conditions. Also, PVP-I-related adverse effects and toxicities and its alternatives are discussed. The goal is to present a thorough evaluation of the available evidence and to offer practical recommendations for clinicians regarding the therapeutic usage of PVP-I in ophthalmology.

Keywords: Conjunctivitis; Endophthalmitis; Eye; Keratitis; Ophthalmology; Polyvinyl pyrrolidone; Povidone-iodine.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None.

References

    1. Ahmed Y, Scott IU, Pathengay A, et al.: Povidone-iodine for endophthalmitis prophylaxis. American journal of ophthalmology. 2014; 157:503–504 - PubMed
    1. Ali FS, Jenkins TL, Boparai RS, et al.: Aqueous chlorhexidine compared with povidone-iodine as ocular antisepsis before intravitreal injection: a randomized clinical trial. Ophthalmology Retina. 2021; 5:788–796 - PubMed
    1. Ali Z, Khadije D, Elahe A, et al.: Prophylaxis of ophthalmia neonatorum comparison of betadine, erythromycin and no prophylaxis. J Trop Pediatr. 2007; 53:388–392 - PubMed
    1. Altan-Yaycioglu R, Sahinoglu-Keskek N, Canan H, et al.: Effect of diluted povidone iodine in adenoviral keratoconjunctivitis on the rate of subepithelial corneal infiltrates. Int J Ophthalmol. 2019; 12:1420–1425 - PMC - PubMed
    1. Apt L, Isenberg S, Yoshimori R, Paez JH: Chemical preparation of the eye in ophthalmic surgery: III. Effect of povidone-iodine on the conjunctiva. Archives of ophthalmology. 1984; 102:728–729 - PubMed

Publication types